Hemorrhagic pericarditis with cardiac tamponade after percutaneous coronary intervention associated with the use of abciximab

Glycoprotein (GP) IIb/IIIa inhibitors, such as abciximab, are used as adjunctive therapy for percutaneous coronary intervention (PCI) in high-risk non-ST-elevation myocardial infarction (NSTEMI) and in ST-elevation myocardial infarction (STEMI), although their effects when used for STEMI are less cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Su-Jin, Yoon, Hee-Jeoung, Her, Sung-Ho, Lee, Jong-Min, An, Ho-Jung, Lee, Yune-Jeong, Jin, Seung-Won
Formato: Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686964/
https://www.ncbi.nlm.nih.gov/pubmed/18787370
http://dx.doi.org/10.3904/kjim.2008.23.3.156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686964/
https://www.ncbi.nlm.nih.gov/pubmed/18787370
http://dx.doi.org/10.3904/kjim.2008.23.3.156

Ejemplares similares